Brief Review of Newer Antiglycemic Agents as Options in the Treatment of Diabetic Kidney Disease
<p>Diabetes remains the leading cause of chronic kidney disease and with its increased prevalence the risk for Diabetic Kidney Disease (DKD) continues to rise and has a significant impact on diabetes morbidity and mortality as well as health care resources. There is a clear need to clinicians...
Na minha lista:
Principais autores: | Brian K Irons (Autor), Molly Minze (Autor), Lisa Chastain (Autor), Michael E McMurry (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications,
2020-05-11.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
por: Minze MG, et al.
Publicado em: (2016) -
Newer management options in leprosy
por: P Narasimha Rao, et al.
Publicado em: (2013) -
Newer Chemortherapeutic Agents In Leprosy
por: Ganapati R, et al.
Publicado em: (1996) -
Bowen’s disease – a review of newer treatment options
por: Thorsten Neubert, et al.
Publicado em: (2008) -
Newer Hemostatic Agents Used in the Practice of Dermatologic Surgery
por: Jill Henley, et al.
Publicado em: (2013)